These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7609506)

  • 1. Evaluation of the renal effects of calcium antagonists.
    Ruilope LM; Lahera V; Rodicio JL
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S49-53. PubMed ID: 7609506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renoprotective effects of antihypertensive drugs.
    Preston RA
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):19S-32S. PubMed ID: 10077416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can calcium channel blockers preserve renal function better than diuretics during antihypertensive treatment?
    Fukuda M; Kimura G
    Arch Intern Med; 2005 Jun; 165(11):1312; author reply 1312-3. PubMed ID: 15956015
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium antagonists and the kidney.
    Epstein M
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S18-24. PubMed ID: 7603073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists and the kidney. Implications for renal protection.
    Epstein M
    Am J Hypertens; 1993 Jul; 6(7 Pt 2):251S-259S. PubMed ID: 8398009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists and renal protection.
    Rodicio JL; Morales JM; Alcázar JM; Ruilope LM
    J Hypertens Suppl; 1993 Mar; 11(1):S49-53. PubMed ID: 8483023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive drugs in renal failure.
    Albert FW
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S108-12. PubMed ID: 7898089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists and the kidney. Implications for renal protection.
    Epstein M
    Am J Hypertens; 1991 Jul; 4(7 Pt 2):482S-486S. PubMed ID: 1910641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonists and renal protection. Current status and future perspectives.
    Epstein M
    Arch Intern Med; 1992 Aug; 152(8):1573-84. PubMed ID: 1497390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
    Expert Opin Investig Drugs; 2010 Sep; 19(9):1027-37. PubMed ID: 20649501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies in antihypertensive therapy: implications of the kidney.
    Hollenberg NK
    Am J Med; 1986 Dec; 81(6A):15-9. PubMed ID: 2879443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective microproteinuria as a marker of incipient renal impairment in patients with hypertension].
    Eremina IuN; Leonova MV; Belousov IuB; Tarasov AV
    Kardiologiia; 2004; 44(10):71-7. PubMed ID: 15477795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do calcium antagonists protect the human hypertensive kidney?
    Bauer JH; Reams GP
    Am J Hypertens; 1989 Jun; 2(6 Pt 2):173S-178S. PubMed ID: 2665788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amlodipine and loop diuretics as the second anti-hypertensive medication for the treatment of hypertension with chronic kidney diseases.
    Takenaka T; Uchida K; Kojima E; Gen S; Nodaira Y; Hoshi H; Kato N; Takane H; Ohno Y; Suzuki H
    Clin Exp Hypertens; 2011; 33(4):210-5. PubMed ID: 21699446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension, nephrosclerosis and calcium antagonists].
    del Río A
    Med Clin (Barc); 1989 Jan; 92(3):98-101. PubMed ID: 2709903
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephro-protection: role of arterial pressure in progression of renal pathology. Does a nephro-protective effect depend on the choice of antihypertensive drug?].
    Shestakova MV
    Ter Arkh; 2001; 73(6):64-6. PubMed ID: 11521527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.